Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 200 shares at $650.15 ($130K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($130k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |
| REGN | SELL | 2024-10-03 | $105K | — | Filing → |